Status:
UNKNOWN
INCA - Intervention and Neuropsychology in Cannabis Abuse
Lead Sponsor:
University Hospital, Bonn
Collaborating Sponsors:
German Federal Ministry of Education and Research
Conditions:
Marijuana Abuse
Eligibility:
All Genders
16-36 years
Phase:
NA
Brief Summary
INCA (Intervention and Neuropsychology of Cannabis Abuse) is a study combining two research goals. One is to study efficacy of a short intervention the 'Problem Profile Intervention', which utilizes i...
Eligibility Criteria
Inclusion
- ASSIST-Score for cannabis consume ≥ 4 ≤ 26
- german mother tongue (or comparable level)
Exclusion
- major current psychiatric disorder (e.g. psychosis)
- addiction to other illegal drugs or alcohol
- recent or current intravenous drug use
- CNS-affecting medication
- current psychotherapy, other treatment for substance use disorder
- exclusion criteria for fMRI-part:
- left-handedness
- medication (birth control pill, thyroid gland hormones possible)
- internistic illnesses (hypertension, diabetes, diseases of lungs)
- metallic implants (cardiac pacemaker, ferromagnetic object implanted through surgical intervention or accident, large-area tattoos)
- history of serious trauma
- claustrophobia
- gestation
Key Trial Info
Start Date :
July 1 2005
Trial Type :
INTERVENTIONAL
End Date :
October 1 2007
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT00279604
Start Date
July 1 2005
End Date
October 1 2007
Last Update
April 20 2007
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Friedrich-Wilhelms-University, Department of Psychiatry
Bonn, North Rhine-Westphalia, Germany, 53105
2
University of Essen, Department of Psychiatry and Psychotherapy
Essen, North Rhine-Westphalia, Germany, 45147